Laparoscopic Use of a Hyaluronic Acid Carboxycellulose Membrane Slurry in Gynecological Oncology by Lipetskaia, Lioudmila & Silver, David F.
Laparoscopic Use of a Hyaluronic Acid
Carboxycellulose Membrane Slurry in
Gynecological Oncology
Lioudmila Lipetskaia, MD, David F. Silver, MD
ABSTRACT
Objectives: We evaluated the use of a hyaluronic acid-
carboxycellulose membrane (HAC) slurry in complex
laparoscopies.
Materials and Methods: A gel-like mixture of HAC was
prepared and applied in 171 consecutive complex lapa-
roscopies on a gynecologic oncology service. The HAC
slurry was used to coat deperitonealized surfaces and
surgical pedicals to prevent postoperative adhesions. The
technique is described and the outcomes are prospec-
tively evaluated for feasibility and safety.
Results: There were no postoperative bowel obstruc-
tions, 1 pelvic hematoma in a patient on clopidogrel
(Plavix) immediately prior to surgery, 8 postoperative ilea,
and 1 bowel perforation. The bowel perforation occurred
in a patient with extensive adhesiolysis and intraoperative
bowel suturing.
Conclusion: This report describes an easy approach to
the laparoscopic application of HAC. Caution should be
taken if HAC slurry is applied after significant bowel
suturing because 1 of 9 patients with extensive adhesioly-
sis requiring suturing of the sigmoid colon developed
sigmoid perforations.
Key Words: Seprafilm, Adhesion prevention, New tech-
nique, Gynecologic oncology surgery.
INTRODUCTION
Hyaluronic acid-carboxycellulose (HAC) membrane has
been FDA-approved, based on randomized trials, for pre-
vention of postoperative adhesions due to surgical proce-
dures performed via laparotomy.1 The use of HAC (Se-
prafilm) has demonstrated a reduction in both
postoperative adhesions and early postoperative obstruc-
tion.2–6 In gynecologic surgeries, the application of HAC
has also demonstrated improvements in postoperative
pelvic pain.7
It is well accepted that minimally invasive laparoscopic
techniques have resulted in less postoperative adhesion
formation. However, as the scope of laparoscopic surger-
ies has expanded to include more advanced intraperito-
neal surgical procedures, the laparoscopic use of adhe-
sion barriers has become a more important consideration.
Several novel techniques for delivery of HAC sheets
through laparoscopic trocars have been described primar-
ily in patients undergoing laparoscopic myomecto-
mies.8–10 Although effective in reducing postoperative
pain, these techniques are cumbersome and time consum-
ing.
Several institutions and gynecologic practices across the
country have utilized a technique of mixing HAC in solu-
tion and injecting it laparoscopically for the purpose of
adhesion prevention. However, very little data are avail-
able in the surgical or gynecologic literature describing its
use.11 This study evaluates 171 consecutive laparoscopic
applications of HAC slurry in patients referred to a gyne-
cologic oncology practice. The purpose of this report is to
evaluate the feasibility and safety of its use.
MATERIALS AND METHODS
Patient Selection
From May 1, 2007 to January 31, 2009, 171 consecutive
laparoscopic surgeries utilized a single technique to apply
HAC slurry. The patients were followed prospectively. A
gynecologic oncologist performed each surgery. Patients
were referred for new diagnoses of potential or previously
diagnosed malignancies. In addition, occasional surgeries
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SCIENTIFIC PAPERwere performed when intraoperative consultations were
requested to repair injuries from benign gynecologic sur-
geries.
Technique
Three sheets of HAC are crumbled and mixed into 60cc of
warm saline at least 5 minutes prior to the anticipated
completion of surgery. Once a gel-like mixture (slurry) is
established, it is poured into a catheter-tipped syringe. A
sterile, 16 French red rubber catheter is attached to the
syringe, and the tip of the catheter is cut off leaving a
single opening through which the slurry can be injected.
The catheter is placed through a trocar 5mm. By man-
ually manipulating the trocar, the tip of the catheter is
guided to precisely apply the slurry. If no trocars are
5mm, then the catheter is placed through a 5-mm trocar
site after the trocar is removed. In this case, the tip of the
catheter can be grasped by a laparoscopic instrument
through another trocar and guided to precisely apply the
slurry. The slurry is used to coat any deperitonealized
areas and surgical pedicals.
Outcomes
Because it was not expected that many laparoscopic sur-
geries would be re-explored, the primary outcomes mea-
sured in this study were not related to adhesion preven-
tion. The patient demographics, types of procedures, and
untoward events following this technique for the laparo-
scopic use of HAC were prospectively monitored and
recorded.
RESULTS
Demographics
The mean age of the patients was 55.2 (SD15.3). The
mean BMI was 32.7 (SD8.1). The race distribution was
as follows: Caucasian 71%, Hispanic 18%, and Black 11%.
Type of Surgical Procedures
The most common procedures performed were total lapa-
roscopic hysterectomy, bilateral salpingo-oophorectomy,
bilateral pelvic and paraaortic lymphadenectomy, which
was performed in 56 (32%) of the patients. In patients who
underwent 98 procedures for benign anomalies, 79 (80%)
had the preoperative diagnosis of a complex ovarian
mass. The variety of cases performed can be seen in Table
1. In 41 (24%) of the surgeries extensive adhesiolysis was
required (defined as adhesiolysis requiring more than 60
minutes) as a part of the procedure, and 9 (5.3%) required
laparoscopic suturing of the sigmoid colon.
Postoperative Outcomes
The median length of stay was 1 day (range, 0 to 8).
Untoward events included the following. There have been
no postoperative bowel obstructions, 1 left obturator
space hematoma that was observed in a patient on clopi-
dogrel (Plavix) immediately prior to surgery for medical
indications, 8 cases of postoperative ileus, and 1 bowel
perforation recognized postoperatively. The bowel perfo-
ration occurred in 1 of 9 (11%) patients with extensive
adhesiolysis and laparoscopic suturing of the sigmoid
colon.
The median length of time of surgery among the 8 patients
who developed a postoperative ileus was 165 minutes
(range, 120 to 210). Part of each of the surgical procedures
included extensive adhesiolysis using hydrodissection
and Endoshear sharp dissection. Electrocautery was not
used to separate adhesions in any cases presented in this
report. Three of the cases also required suturing of the
sigmoid colon. Ileus was diagnosed on postoperative day
1 in each of these patients when they demonstrated intol-
erance of oral intake, and abdominal x-rays described
dilated loops of small and large bowel. Conservative man-
agement with bowel rest until flatus was undertaken. Five
patients were discharged home on postoperative day #3,
Table 1.
List of 171 Laparoscopic Procedures
Procedures*† Number
Salpingo-oophorectomy  hysterectomy 109
Total hysterectomy  salpingo-oophorectomy 102
Lymph node dissection 63
Trachelectomy 5
Staging biopsy 5
Partial omentectomy 5
Cystotomy repair 2
Ureteroneocystostomy 2
Myomectomy 2
Sacrocolpopexy 1
*Laparoscopic surgeries included several of the above-listed pro-
cedures concomitantly.
†Final pathology was benign for 98 procedures performed and
malignant for 73 procedures performed.
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of their ileus.
In the case that was complicated by a postoperative bowel
perforation after laparoscopic suturing of the sigmoid, the
patient was discharged home on postoperative day #2
after demonstrating tolerance of a regular diet for both
breakfast and lunch. On postoperative day #4, she re-
turned to the emergency department after having a sud-
den onset of severe abdominal pain. A computed tomo-
graphic scan demonstrated free air in the abdomen and a
collection of fluid in the pelvis. She was taken to the
operating room where she underwent an exploratory lap-
arotomy, peritoneal washout, and suture repair of a sig-
moid perforation at the site of her previous laparoscopic
suture repair. At laparotomy, the sigmoid colon defect was
sutured in a single layer using 3–0 PDS suture. The patient
tolerated liquids on postoperative day #2 and advanced to
a regular diet after passage of flatus on day #4. She was
discharged home on day #5.
CONCLUSION
Historically, HAC was FDA approved for adhesion pre-
vention during laparotomy. With proven efficacy at lapa-
rotomy and the trend toward increasing radicality of lapa-
roscopic surgeries, there is a growing interest in
identifying an easy method to incorporate the use of HAC
during laparoscopic surgical procedures. Several novel
techniques of delivery of the HAC sheet through trocar
incisions have been described. The laparoscopic place-
ment of HAC sheets has shown benefits in reduction of
pelvic pain in gynecologic surgery; however, these tech-
niques are not widely used due to technical difficulty.
Previous reports of HAC in gynecologic laparoscopy have
been predominantly limited to application during laparo-
scopic myomectomy.8–10
This report is among the first to demonstrate the use of
HAC slurry in a large cohort of gynecologic patients un-
dergoing laparoscopic surgeries. It is the first to describe
its use in a cohort largely made up of gynecologic cancer
patients and complex pelvic surgeries. Although 8 post-
operative ilea in 171 routine laparoscopic cases would be
more than expected, it is easily justified in a series of
patients who undergo laparoscopic procedures with this
degree of complexity. In a single patient with extensive
pelvic adhesiolysis and suturing of the sigmoid colon, we
encountered a postoperative perforation at the site of
suture repair. It should be noted that in 9 total suture
repairs of the sigmoid after extensive adhesiolysis, only 1
perforation occurred. Though this anecdotal incident may
not represent a complication related to the HAC slurry
application, it may be prudent to avoid its use over areas
of significant suturing of the intestinal tract. This is rela-
tively consistent with established recommendations not to
coat bowel anastomoses with HAC sheets at the time of
laparotomy.
It is recognized that the weakness of this report lies in the
fact that it is observational and lacks a comparison group.
Despite this, the information gleaned from this report adds
to the documented knowledge about the safety and fea-
sibility of the HAC slurry to attempt to prevent adhesions
in the postoperative setting following laparoscopic surgi-
cal procedures with a high degree of complexity. While
many believe that adhesion prevention with this tech-
nique should be similar to the use of HAC sheets, this has
not been proven in clinical evaluations, nor was this the
intent of the current report. However, in preclinical animal
models, the HAC slurry demonstrated marked adhesion
prevention.12 Therefore, it not unreasonable to assume
that mixing HAC in physiologic solution should change its
composition or function significantly more than allowing
it to mix into physiologic body fluids after it is placed as a
sheet.
The report describes an easy approach to the laparoscopic
application of HAC slurry to pelvic surfaces following a
variety of gynecologic surgical procedures. Definitive
statements on the effectiveness of the technique cannot be
drawn from this experience, because second-look proce-
dures were not used to evaluate the formation of postop-
erative adhesions. However, it is notable that no bowel
obstructions have occurred in 171 complex pelvic lapa-
roscopies. The data demonstrate that HAC slurry can be
applied safely at the completion of laparoscopic gyneco-
logic procedures. With greater use of this technique and
future clinical investigation including second-look proce-
dures, the efficacy of the HAC slurry may be better eluci-
dated. Furthermore, with industry innovations, other
means of laparoscopic application of HAC may become
more widely available.
References:
1. Kling J. Genzyme’s Seprafilm gets FDA marketing nod. Nat
Biotechnol. 1996;14(5):572.
2. Diamond MP. Reduction of adhesions after uterine myomec-
tomy by Seprafilm membrane (HAL-F): a blinded, prospective,
randomized, multicenter clinical study. Seprafilm Adhesion
Study Group. Fertil Steril. 1996 Dec;66(6):904–910.
3. Beck DE, Cohen Z, Fleshman JW, Kaufman HS, van Goor H,
Wolff BG; Adhesion Study Group Steering Committee. A pro-
JSLS (2010)14:91–94 93spective, randomized, multicenter, controlled study of the safety
of Seprafilm adhesion barrier in abdominopelvic surgery of the
intestine. Dis Colon Rectum. 2003;46(10):1310–1319.
4. Cohen Z, Senagore AJ, Dayton MT, et al. Prevention of
postoperative abdominal adhesions by a novel, glycerol/sodium
hyaluronate/carboxymethylcellulose-based bioresorbable mem-
brane: a prospective, randomized, evaluator-blinded multicenter
study. Dis Colon Rectum. 2005;48(6):1130–1139.
5. Mohri Y, Uchida K, Araki T, et al. Hyaluronic acid-carboxy-
cellulose membrane (Seprafilm) reduces early postoperative
small bowel obstruction in gastrointestinal surgery. Am Surg.
2005;71(10):861–863.
6. Fuazio VW, Cohen Z, Fleshman WU, et al. Reduction in
adhesive small-bowel obstruction by Seprafilm adhesion barrier
after intestinal resection. Dis. Colon Rectum. 2006;49(1):1–11.
7. Khaitan L, Scholz S, Houston HL, Richards WO. Results after
laparoscopic lysis of adhesions and placement of Seprafilm for
intractable abdominal pain. Surg Endosc. 2003;17(2):247–53.
8. Chuang YC, Fan CN, Cho FN, Kan YY, Chang YH, Kang HY.
A novel technique to apply a Seprafilm (hyaluronate-carboxym-
ethylcellulose) barrier following laparoscopic surgeries. Fertil
Steril. 2008;90(5):1959–1963.
9. Khaitan E, Scholz S, Richards WO. Laparoscopic adhesiolysis
and placement of Seprafilm: a new technique and novel ap-
proach to patients with intractable abdominal pain. J Laparoen-
dosc Adv Surg Tech A. 2002;12(4):241–247.
10. Takeuchi H, Kitade M, Kikuchi I, Shimanuki H, Kinoshita K.
A novel instrument and technique for using seprafilm hyaluronic
acid/carboxymethylcellulose membrane during laparoscopic
myomectomy. J Laparoendosc Adv Surg Tech A. 2006;16(5):497–
502.
11. Fenton BW, Fanning J. Laparoscopic application of hyaluro-
nate/ carboxymethylcellulose slurry: An adhesion barrier in a
slurry formation goes where the available sheets cannot. Am J
Obstet Gynecol 2008;199(3):325.
12. Greenawalt K, Colt J, Corazzini R, Krauth M, Holmdahl L. An
evaluation of the adhesion reduction efficiency of Seprafilm
bioresorbable membrane applied as a slurry in two preclinical
models. J Min Invas Gynecol. 2008;15:9S.
Laparoscopic Use of a Hyaluronic Acid Carboxycellulose Membrane Slurry in Gynecological Oncology, Lipetskaia L et al..
JSLS (2010)14:91–94 94